Your LDL Is Above Target: What Actually Brings It Down

Once you know your LDL target — below 70 mg/dL for most people with diabetes and extra cardiovascular risk, below 55 mg/dL if you already have heart or artery disease — the next question is the practical one. Your report says 112. What actually closes that gap, and how much can each thing realistically do?

This is where a lot of well-meaning effort gets spent in the wrong place. People overhaul their diet for six months, see LDL drop by eight points, and conclude that nothing works. In fact everything worked exactly as much as it was ever going to — the effort was just aimed at the smaller lever first.

The biggest lever is usually the one already in your hand

If you have been prescribed a statin, the dose and the drug are doing most of the available work, and there is a wide range inside "taking a statin." StatPearls' review of statin medications (opens in a new tab) sorts them into three intensity bands by how much LDL they are expected to remove:

So the gap between simvastatin 10 mg and atorvastatin 40 mg is not a small tweak — it is roughly the difference between removing a quarter of your LDL and removing more than half of it. If your LDL is sitting stubbornly above target, the first thing worth checking is which band you are actually in. Many people in Pakistan are on a low or moderate dose that was started years ago and never revisited.

The other half of that lever is simply taking it. A tablet taken five nights a week is not a moderate-intensity statin; it is something less. If you have been skipping doses — because of cost, because of a forgotten refill, because of a muscle ache you never mentioned — that is the honest thing to raise at the next visit, and it is a far more common explanation for an off-target LDL than diet is.

What food can and cannot do to LDL

Diet genuinely lowers LDL. It just has a ceiling, and knowing where that ceiling sits saves a lot of frustration. StatPearls' review of dietary therapy for LDL reduction (opens in a new tab) puts typical dietary therapy at an 8% to 15% LDL reduction, against 20% to 50% for statins. A very thorough combined approach — plant sterols, viscous fibre, plant protein and nuts all together — reaches 13% to 30%, which is real, but that is the top of the range for a diet followed closely.

Within diet, the two levers with the clearest evidence are worth knowing individually.

Swapping saturated fat for unsaturated fat. Replacing about 5% of your daily energy from saturated fat with unsaturated fat is associated with roughly a 5% to 10% drop in LDL. In a Pakistani kitchen that is a fairly specific list: desi ghee and butter in curries and on parathas, malai and cream, the fat on mutton and beef, and the deep-fried side of things — samosas, pakoras, puri. Cooking the same curry in a vegetable oil instead of ghee, and moving fried items from daily to occasional, is the change this evidence describes. Nobody has to give up ghee entirely for this to count.

Adding soluble fibre. This is the one most people underuse, and it fits Pakistani eating unusually well — daal, chana, beans, oats and barley are already familiar food, not an imported health project.

Isabgol: the cheapest thing on this list

Psyllium husk — isabgol, sold in every kiryana store and pharmacy in Pakistan as a laxative — has a stronger evidence base for LDL than almost anything else you can buy without a prescription. A meta-analysis of 28 randomised trials in the American Journal of Clinical Nutrition (opens in a new tab)03007-6/fulltext) pooled 1,924 participants and found that a median dose of about 10.2 g of psyllium per day lowered LDL cholesterol by 0.33 mmol/L — roughly 13 mg/dL. It also lowered non-HDL cholesterol and apolipoprotein B, which matter particularly in diabetes, where the LDL number understates the risk.

Thirteen points is not a statin. But it is a genuine, measurable amount from a sachet that costs very little, and it stacks with whatever else you are doing rather than replacing it.

When the statin and the diet still aren't enough

Sometimes the maximum statin dose you can tolerate, plus everything reasonable at the table, still leaves LDL above target. This is common and it is not a failure — it is what the next tier of treatment exists for. The American Diabetes Association's Standards of Care (opens in a new tab) say that when multiple additional cardiovascular risk factors are present and LDL stays at or above 70 mg/dL on maximally tolerated statin therapy, adding ezetimibe or a PCSK9 inhibitor may be reasonable. For people who genuinely cannot tolerate a statin at all, bempedoic acid is listed as an option.

Availability and cost of these differ a lot in Pakistan — ezetimibe is the most accessible of them by some margin — so this is a conversation to have with your physician or cardiologist rather than a decision to research alone.

Give the change time, then measure it

None of this is visible from how you feel. The only way to know whether a dose change, a diet change or a daily isabgol did anything is a repeat lipid profile — and the ADA notes that checking lipids after starting statin treatment makes it more likely the dose gets adjusted properly and that people stay on the plan. Change one meaningful thing, hold it for a couple of months, and recheck. Changing four things at once and testing after two weeks tells you almost nothing.

Track LDL the way you track HbA1c

An LDL number only means something next to the one before it. Log each lipid profile in Diatic alongside what changed — a new dose, a new routine — so the next report answers a question instead of just adding a number.

Log a lab result (opens Diatic on Google Play in a new tab)